RESUMEN
This work is focused on the role of temperature in the de-mixing of absorbance spectra measured in mixed aqueous Na2SO4 and NaNO3 solutions. First, the influence of temperature on the absorbance spectrum of demineralized water was determined. Second, the absorbance spectra of five separate electrolytes (NaNO2, NaNO3, CaCl2, K2CO3, and NaOH) at three temperatures (4°C, 25°C, and 50°C) for concentrations ranging from 0.0625 M to 0.5 M were examined. These five electrolytes show similar temperature dependencies. Finally, absorbance spectra of mixed solutions were investigated at temperatures of 5°C, 15°C, 25°C, 35°C, and 45°C for concentrations ranging from 0.0625 M to 0.5 M per electrolyte in the mixture. The spectral window from 650 to 1100 nm was utilized to observe the ionic and temperature influences on the vibrational modes of the OH bond in the solvent molecules. The effects of dissolving Na2SO4 and NaNO3 are nonlinearly cumulative at lower temperatures indicating extended alteration of the water structure beyond the first hydration shell. A similar trend was observed for a mixture of Na2CO3 and NaCl. Furthermore, it was found that higher temperatures are better for recovering the separate component absorption signatures of an electrolyte mixture. The near-infrared spectral regime is well suited for integrated sensing, and therefore these results can help in designing an integrated sensor to identify inorganic species in water.
RESUMEN
The American cockroach, Periplaneta americana, provides a successful model for the study of legged locomotion. Sensory regulation and the relative importance of sensory feedback vs. central control in animal locomotion are key aspects in our understanding of locomotive behavior. Here we introduce the cockroach model and describe the basic characteristics of the neural generation and control of walking and running in this insect. We further provide a brief overview of some recent studies, including mathematical modeling, which have contributed to our knowledge of sensory control in cockroach locomotion. We focus on two sensory mechanisms and sense organs, those providing information related to loading and unloading of the body and the legs, and leg-movement-related sensory receptors, and present evidence for the instrumental role of these sensory signals in inter-leg locomotion control. We conclude by identifying important open questions and indicate future perspectives.
Asunto(s)
Cucarachas/fisiología , Retroalimentación Sensorial/fisiología , Locomoción/fisiología , Animales , Ganglios de Invertebrados/fisiología , Modelos NeurológicosRESUMEN
Current methods to remove donor-specific HLA antibody (DSA) from sensitized patients remain imperfect. We tested novel approaches to desensitization using an animal model of allogeneic sensitization with skin grafts from dark agouti (DA) to Lewis rats. At the peak IgG alloantibody response we transplanted DA kidneys into nephrectomized Lewis recipients (n = 6) and all died within 10 days from antibody-mediated rejection (AMR). Allogeneic hematopoietic stem cell transplants (HSCT) from DA donors failed to engraft after lethal or sub-lethal irradiation. Sensitized rats given lethal irradiation plus syngeneic green fluorescent protein (GFP) + HSCT had repopulation of blood, spleen, thymus and lymph nodes by GFP+ cells. At 2 months after HSCT, serum DSA levels were reduced 60-70% and DSA (IgG) production in cultured splenocytes was also significantly decreased. However, there was only a modest improvement in graft survival from an average of 6.5 to 13.9 (n = 9) days. Adding seven daily doses of fludarabine to the preconditioning regimen resulted in long-term survival (>90 days) in 7 out of 10 rat kidney allografts. We conclude that syngeneic HSCT performed after preconditioning with irradiation and fludarabine can reduce DSA, prevent DSA rebound and AMR, enabling successful transplantation in animals with strong antibody reactivity to the donor MHC.
Asunto(s)
Trasplante de Células Madre Hematopoyéticas , Trasplante de Riñón , Vidarabina/análogos & derivados , Animales , Secuencia de Bases , Cartilla de ADN , Femenino , Reacción en Cadena de la Polimerasa , Ratas , Ratas Endogámicas Lew , Vidarabina/administración & dosificaciónRESUMEN
Botulinum neurotoxin A is a category A bioterrorism agent. Current antitoxin therapies are scarce and produce adverse reactions. XOMA 3AB consists of 3 IgG1 monoclonal antibodies (MAbs), each with a distinct human or humanized variable region, which bind to distinct epitopes on botulinum neurotoxin serotype A. This first-in-human study evaluated the safety and pharmacokinetics (PK) of escalating doses of XOMA 3AB administered intravenously (i.v.) to healthy adults. In this double-blind placebo-controlled dose escalation study, 3 cohorts of 8 healthy subjects received a single intravenous dose of XOMA 3AB or placebo at a 3:1 ratio. Follow-up examinations included physical examinations, hematology and chemistry blood tests, electrocardiograms, and pharmacokinetics. Pharmacokinetic parameters were estimated using noncompartmental methods. There were no infusion discontinuations or hypersensitivity reactions. Two or more subjects experienced headache, hyperglycemia, or anemia; none was dose related. All adverse events (AEs) were mild to moderate except for an episode of exercise-induced elevation of a subject's creatine phosphokinase (CPK) level, unrelated to XOMA 3AB. Concentration-time plots demonstrated a peak in MAb concentrations 1 to 2 h after completion of the infusion, after which the levels declined in a biexponential decay pattern for all analytes. For each MAb, the maximum concentration of drug in serum (Cmax) and the area under the concentration-time curve from 0 to infinity (AUCinf) increased as the dose increased. Clearance of the humanized mouse MAb was more rapid than that of the two fully human MAbs, particularly at the lowest dose. None of the MAbs was immunogenic. At the doses administered, XOMA 3AB was well tolerated. These safety findings support further investigation of XOMA 3AB as a potential agent for botulism treatment and postexposure prophylaxis. (This study has been registered at ClinicalTrials.gov under registration no. NCT01357213.).
Asunto(s)
Anticuerpos Monoclonales/efectos adversos , Anticuerpos Monoclonales/farmacocinética , Toxinas Botulínicas Tipo A/antagonistas & inhibidores , Adulto , Animales , Área Bajo la Curva , Método Doble Ciego , Femenino , Humanos , Masculino , Ratones , Adulto JovenRESUMEN
Located at the interface between body and environment, the epidermis must protect the body against toxic agents and dehydration, and protect itself against physical and mechanical stresses. Acquired just before birth and at the last stage of epidermal differentiation, the skin's proteinaceous/lipid barrier creates a surface seal essential for protecting animals against microbial infections and dehydration. We show here that Kruppel-like factor 4 (Klf4, encoded by the gene Klf4), highly expressed in the differentiating layers of epidermis, is both vital to and selective for barrier acquisition. Klf4-/- mice die shortly after birth due to loss of skin barrier function, as measured by penetration of external dyes and rapid loss of body fluids. The defect was not corrected by grafting of Klf4-/- skin onto nude mice. Loss of the barrier occurs without morphological and biochemical alterations to the well-known structural features of epidermis that are essential for mechanical integrity. Instead, late-stage differentiation structures are selectively perturbed, including the cornified envelope, a likely scaffold for lipid organization. Using suppressive subtractive hybridization, we identified three transcripts encoding cornified envelope proteins with altered expression in the absence of Klf4. Sprr2a is one, and is the only epidermal gene whose promoter is known to possess a functional Klf4 binding site. Our studies provide new insights into transcriptional governance of barrier function, and pave the way for unravelling the molecular events that orchestrate this essential process.
Asunto(s)
Proteínas de Unión al ADN , Epidermis/fisiología , Factores de Transcripción/fisiología , Animales , Peso Corporal , Epidermis/anatomía & histología , Epidermis/embriología , Epidermis/ultraestructura , Factor 4 Similar a Kruppel , Factores de Transcripción de Tipo Kruppel , Ratones , Ratones Desnudos , Microscopía Inmunoelectrónica , Modelos Genéticos , Mutagénesis , Trasplante de Piel , Factores de Tiempo , Lengua/anatomía & histología , Lengua/embriología , Factores de Transcripción/análisis , Factores de Transcripción/metabolismoRESUMEN
WNT signalling orchestrates a number of developmental programs. In response to this stimulus, cytoplasmic beta-catenin (encoded by CTNNB1) is stabilized, enabling downstream transcriptional activation by members of the LEF/TCF family. One of the target genes for beta-catenin/TCF encodes c-MYC, explaining why constitutive activation of the WNT pathway can lead to cancer, particularly in the colon. Most colon cancers arise from mutations in the gene encoding adenomatous polyposis coli (APC), a protein required for ubiquitin-mediated degradation of beta-catenin, but a small percentage of colon and some other cancers harbour beta-catenin-stabilizing mutations. Recently, we discovered that transgenic mice expressing an activated beta-catenin are predisposed to developing skin tumours resembling pilomatricomas. Given that the skin of these adult mice also exhibits signs of de novo hair-follicle morphogenesis, we wondered whether human pilomatricomas might originate from hair matrix cells and whether they might possess beta-catenin-stabilizing mutations. Here, we explore the cell origin and aetiology of this common human skin tumour. We found nuclear LEF-1 in the dividing tumour cells, providing biochemical evidence that pilomatricomas are derived from hair matrix cells. At least 75% of these tumours possess mutations affecting the amino-terminal segment, normally involved in phosphorylation-dependent, ubiquitin-mediated degradation of the protein. This percentage of CTNNB1 mutations is greater than in all other human tumours examined thus far, and directly implicates beta-catenin/LEF misregulation as the major cause of hair matrix cell tumorigenesis in humans.
Asunto(s)
Proteínas del Citoesqueleto/genética , Enfermedades del Cabello/genética , Mutación , Pilomatrixoma/genética , Neoplasias Cutáneas/genética , Transactivadores , Secuencia de Aminoácidos , Proteínas de Unión al ADN/análisis , Proteínas de Unión al ADN/metabolismo , Desoxirribonucleasas de Localización Especificada Tipo II/genética , Frecuencia de los Genes , Enfermedades del Cabello/patología , Humanos , Factor de Unión 1 al Potenciador Linfoide , Datos de Secuencia Molecular , Pilomatrixoma/patología , Reacción en Cadena de la Polimerasa , Análisis de Secuencia de ADN , Neoplasias Cutáneas/patología , Factores de Transcripción/análisis , Factores de Transcripción/metabolismo , beta CateninaRESUMEN
In the post-genome era, the mouse will have a major role as a model system for functional genome analysis. This requires a large number of mutants similar to the collections available from other model organisms such as Drosophila melanogaster and Caenorhabditis elegans. Here we report on a systematic, genome-wide, mutagenesis screen in mice. As part of the German Human Genome Project, we have undertaken a large-scale ENU-mutagenesis screen for dominant mutations and a limited screen for recessive mutations. In screening over 14,000 mice for a large number of clinically relevant parameters, we recovered 182 mouse mutants for a variety of phenotypes. In addition, 247 variant mouse mutants are currently in genetic confirmation testing and will result in additional new mutant lines. This mutagenesis screen, along with the screen described in the accompanying paper, leads to a significant increase in the number of mouse models available to the scientific community. Our mutant lines are freely accessible to non-commercial users (for information, see http://www.gsf.de/ieg/groups/enu-mouse.html).
Asunto(s)
Etilnitrosourea/farmacología , Genoma , Mutágenos/farmacología , Mutación/efectos de los fármacos , Animales , Cruzamientos Genéticos , Criopreservación , Femenino , Miembro Anterior/anomalías , Inmunidad/genética , Inmunidad/inmunología , Inmunoglobulina E/sangre , Inmunoglobulina G/sangre , Inmunoglobulina M/sangre , Masculino , Ratones , Ratones Endogámicos C3H , Ratones Endogámicos C57BL , Mutagénesis , Mutación/genética , Mutación/inmunología , FenotipoRESUMEN
Colistimethate sodium, increasingly used to treat multidrug-resistant Gram-negative infections, spontaneously hydrolyzes to form colistin A (polymyxin E1) and B (polymyxin E2/B) when mixed with water. High levels of these active breakdown products at the time of administration have been associated with nephrotoxicity and even death. In this study, reconstituted colistimethate sodium was shown to be stable (<1.0% colistin A/B formation) for up to 24 h when stored at 21, 0, -20, and -70°C.
Asunto(s)
Antibacterianos/química , Colistina/análogos & derivados , Colistina/química , Composición de Medicamentos , Estabilidad de Medicamentos , Soluciones Farmacéuticas , Espectrometría de Masas en Tándem , Temperatura , AguaRESUMEN
The human brain is distinguished by its remarkable size, high energy consumption, and cognitive abilities compared to all other mammals and non-human primates. However, little is known about what has accelerated brain evolution in the human lineage. One possible explanation is that the appearance of advanced communication skills and language has been a driving force of human brain development. The phenotypic adaptations in brain structure and function which occurred on the way to modern humans may be associated with specific molecular signatures in today's human genome and/or transcriptome. Genes that have been linked to language, reading, and/or autism spectrum disorders are prime candidates when searching for genes for human-specific communication abilities. The database and genome-wide expression analyses we present here revealed a clustering of such communication-associated genes (COAG) on human chromosomes X and 7, in particular chromosome 7q31-q36. Compared to the rest of the genome, we found a high number of COAG to be differentially expressed in the cortices of humans and non-human primates (chimpanzee, baboon, and/or marmoset). The role of X-linked genes for the development of human-specific cognitive abilities is well known. We now propose that chromosome 7q31-q36 also represents a hot spot for the evolution of human-specific communication abilities. Selective pressure on the T cell receptor beta locus on chromosome 7q34, which plays a pivotal role in the immune system, could have led to rapid dissemination of positive gene variants in hitchhiking COAG.
Asunto(s)
Corteza Cerebral/metabolismo , Cromosomas Humanos Par 7/genética , Comunicación , Transcriptoma , Adulto , Animales , Mapeo Cromosómico , Cromosomas de los Mamíferos/genética , Análisis por Conglomerados , Evolución Molecular , Perfilación de la Expresión Génica , Genoma Humano/genética , Humanos , Masculino , Persona de Mediana Edad , Análisis de Secuencia por Matrices de Oligonucleótidos , Primates/genética , Receptores de Antígenos de Linfocitos T alfa-beta/genética , SinteníaRESUMEN
The autism susceptibility locus on human chromosome 7q32 contains the maternally imprinted MEST and the non-imprinted COPG2 and TSGA14 genes. Autism is a disorder of the 'social brain' that has been proposed to be due to an overbalance of paternally expressed genes. To study regulation of the 7q32 locus during anthropoid primate evolution, we analyzed the methylation and expression patterns of MEST, COPG2, and TSGA14 in human, chimpanzee, Old World monkey (baboon and rhesus macaque), and New World monkey (marmoset) cortices. In all human and anthropoid primate cortices, the MEST promoter was hemimethylated, as expected for a differentially methylated imprinting control region, whereas the COPG2 and TSGA14 promoters were completely demethylated, typical for transcriptionally active non-imprinted genes. The MEST gene also showed comparable mRNA expression levels in all analyzed species. In contrast, COPG2 expression was downregulated in the human cortex compared to chimpanzee, Old and New World monkeys. TSGA14 either showed no differential regulation in the human brain compared to chimpanzee and marmoset or a slight upregulation compared to baboon. The human-specific downregulation supports a role for COPG2 in the development of a 'social brain'. Promoter methylation patterns appear to be more stable during evolution than gene expression patterns, suggesting that other mechanisms may be more important for inter-primate differences in gene expression.
Asunto(s)
Trastornos Generalizados del Desarrollo Infantil/genética , Cromosomas Humanos Par 7/genética , Proteína Coatómero/genética , Primates/genética , Proteínas/genética , Adulto , Anciano , Anciano de 80 o más Años , Animales , Secuencia de Bases , Callithrix , Corteza Cerebral/metabolismo , Niño , Metilación de ADN , Cartilla de ADN/genética , Evolución Molecular , Femenino , Predisposición Genética a la Enfermedad , Impresión Genómica , Humanos , Macaca mulatta , Masculino , Persona de Mediana Edad , Datos de Secuencia Molecular , Pan troglodytes , Papio hamadryas , Regiones Promotoras Genéticas , Homología de Secuencia de Ácido Nucleico , Especificidad de la Especie , Adulto JovenRESUMEN
When a high-voltage direct-current is applied to two beakers filled with water, a horizontal electrohydrodynamic (EHD) bridge forms between the two beakers. In this work we study the transport and behavior of bacterial cells added to an EHD bridge set-up. Organisms were added to one or to both beakers, and the transport of the cells through the bridge was monitored using optical and microbiological techniques. It is shown that Escherichia coli top10 (Invitrogen, Carlsbad, CA, USA) and bioluminescent E. coli YMC10 with a plasmid (pJE202) containing Vibrio fischeri genes can survive the exposure to an EHD liquid bridge set-up and the cells are drawn toward the anode due to their negative surface charge. Dielectrophoresis and hydrostatic forces are likely to be the cause for their transport in the opposite direction which was observed as well, but to a much lesser extent. Most E. coli YMC10 bacteria which passed the EHD bridge exhibited increased luminescent activity after 24 h. This can be explained by two likely mechanisms: nutrient limitation in the heavier inoculated vials and a 'survival of the strongest' mechanism.
RESUMEN
BACKGROUND: Current knowledge about the optimal energy and nutrient supply for common marmoset monkeys (Callithrix jacchus) is scarce, and more information is needed for establishing the underlying nutritional concepts for facilitating longevity of this species as laboratory animals for biomedical research. METHODS: Two feeding experiments were conducted to yield fundamental data about feed acceptance, real feed intake, and feed preferences under laboratory conditions. Newly developed feeding concepts for marmoset monkeys were also examined in preliminary investigations to compare the outcomes with those of a commercial pelletized mixed feed. RESULTS: The first experiments showed preferences for main protein sources in the diets studied, specifically that plant proteins are more accepted than fish meal or egg protein as the main protein source. Several aroma supplements did not modify the acceptance and feed intake markedly. CONCLUSIONS: The newly developed feeding concept yielded promising preliminary data for long-term studies of energy and nutrient supply under laboratory conditions. However, studies of the fundamental requirements are still needed.
Asunto(s)
Crianza de Animales Domésticos/métodos , Fenómenos Fisiológicos Nutricionales de los Animales/fisiología , Animales de Laboratorio , Callithrix/fisiología , Metabolismo Energético/fisiología , Preferencias Alimentarias/fisiología , Animales , Peso Corporal , Ingestión de Alimentos/fisiología , Femenino , Ciencia de los Animales de Laboratorio , MasculinoRESUMEN
BACKGROUND: Patients with metastatic breast cancer (MBC) overexpressing HER2 (human epidermal growth factor receptor 2) are currently selected for treatment with trastuzumab, but not all patients respond. PATIENTS AND METHODS: Using a novel assay, HER2 protein expression (H2T) was measured in formalin-fixed, paraffin-embedded primary breast tumors from 98 women treated with trastuzumab-based therapy for MBC. Using subpopulation treatment effect pattern plots, the population was divided into H2T low (H2T < 13.8), H2T high (H2T ≥ 68.5), and H2T intermediate (13.8 ≤ H2T < 68.5) subgroups. Kaplan-Meier (KM) analyses were carried out comparing the groups for time to progression (TTP) and overall survival (OS). Cox multivariate analyses were carried out to identify correlates of clinical outcome. Bootstrapping analyses were carried out to test the robustness of the results. RESULTS: TTP improved with increasing H2T until, at the highest levels of H2T, an abrupt decrease in the TTP was observed. KM analyses demonstrated that patients with H2T low tumors [median TTP 4.2 months, hazard ratio (HR) = 3.7, P < 0.0001] or H2T high tumors (median TTP 4.6 months, HR = 2.7, P = 0.008) had significantly shorter TTP than patients whose tumors were H2T intermediate (median TTP 12 months). OS analyses yielded similar results. CONCLUSIONS: MBC patients with very high levels of H2T may represent a subgroup with de novo resistance to trastuzumab. These results are preliminary and require confirmation in larger controlled clinical cohorts.
Asunto(s)
Anticuerpos Monoclonales Humanizados/uso terapéutico , Antineoplásicos/uso terapéutico , Neoplasias de la Mama/tratamiento farmacológico , Neoplasias de la Mama/enzimología , Receptor ErbB-2/biosíntesis , Neoplasias de la Mama/genética , Estudios de Cohortes , Resistencia a Antineoplásicos , Femenino , Amplificación de Genes , Dosificación de Gen , Humanos , Inmunohistoquímica , Hibridación Fluorescente in Situ , Modelos de Riesgos Proporcionales , Estudios Prospectivos , Receptor ErbB-2/genética , Trastuzumab , Resultado del TratamientoRESUMEN
Recent advances in the field of intercellular adhesion highlight the importance of adherens junction association with the underlying actin cytoskeleton. In skin epithelial cells a dynamic feature of adherens junction formation involves filopodia, which physically project into the membrane of adjacent cells, catalyzing the clustering of adherens junction protein complexes at their tips. In turn, actin polymerization is stimulated at the cytoplasmic interface of these complexes. Although the mechanism remains unclear, the VASP/Mena family of proteins seems to be involved in organizing actin polymerization at these sites. In vivo, adherens junction formation appears to rely upon filopodia in processes where epithelial sheets must be physically moved closer to form stable intercellular connections, for example, in ventral closure in embryonic development or wound healing in the postnatal animal.
Asunto(s)
Actinas/fisiología , Comunicación Celular/fisiología , Células Epiteliales/citología , Células Epiteliales/fisiología , Uniones Adherentes/fisiología , Animales , Adhesión Celular/fisiología , Espacio Extracelular/fisiología , HumanosRESUMEN
We have generated an epidermis-specific desmoplakin (DP) mouse knockout, and show that epidermal integrity requires DP; mechanical stresses to DP-null skin cause intercellular separations. The number of epidermal desmosomes in DP-null skin is similar to wild type (WT), but they lack keratin filaments, which compromise their function. DP-null keratinocytes have few desmosomes in vitro, and are unable to undergo actin reorganization and membrane sealing during epithelial sheet formation. Adherens junctions are also reduced. In vitro, DP transgene expression rescues these defects. DP is therefore required for assembly of functional desmosomes, maintaining cytoskeletal architecture and reinforcing membrane attachments essential for stable intercellular adhesion.
Asunto(s)
Proteínas del Citoesqueleto/genética , Proteínas del Citoesqueleto/metabolismo , Epidermis/anomalías , Uniones Adherentes/patología , Uniones Adherentes/ultraestructura , Animales , Membrana Basal/química , Adhesión Celular/fisiología , Células Cultivadas , Proteínas del Citoesqueleto/análisis , Citoesqueleto/química , Citoesqueleto/patología , Desmoplaquinas , Desmosomas/patología , Desmosomas/ultraestructura , Epidermis/patología , Regulación del Desarrollo de la Expresión Génica , Queratinocitos/patología , Queratinocitos/fisiología , Queratinas/metabolismo , Ratones , Ratones Noqueados , Microscopía Electrónica , Fenotipo , Estrés MecánicoRESUMEN
TRAIL (tumour-necrosis factor-related apoptosis ligand or Apo2L) triggers apoptosis through engagement of the death receptors TRAIL-R1 (also known as DR4) and TRAIL-R2 (DR5). Here we show that the c-Rel subunit of the transcription factor NF-kappaB induces expression of TRAIL-R1 and TRAIL-R2; conversely, a transdominant mutant of the inhibitory protein IkappaBalpha or a transactivation-deficient mutant of c-Rel reduces expression of either death receptor. Whereas NF-kappaB promotes death receptor expression, cytokine-mediated activation of the RelA subunit of NF-kappaB also increases expression of the apoptosis inhibitor, Bcl-xL, and protects cells from TRAIL. Inhibition of NF-kappaB by blocking activation of the IkappaB kinase complex reduces Bcl-x L expression and sensitizes tumour cells to TRAIL-induced apoptosis. The ability to induce death receptors or Bcl-xL may explain the dual roles of NF-kappaB as a mediator or inhibitor of cell death during immune and stress responses.
Asunto(s)
Regulación de la Expresión Génica , Proteínas I-kappa B , Glicoproteínas de Membrana/metabolismo , FN-kappa B/metabolismo , Proteínas Proto-Oncogénicas c-rel/metabolismo , Receptores del Factor de Necrosis Tumoral/genética , Factor de Necrosis Tumoral alfa/metabolismo , Animales , Apoptosis , Proteínas Reguladoras de la Apoptosis , Proteínas de Unión al ADN/metabolismo , Células HeLa , Humanos , Glicoproteínas de Membrana/farmacología , Ratones , Inhibidor NF-kappaB alfa , FN-kappa B/genética , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Proteínas Proto-Oncogénicas c-rel/genética , Tolerancia a Radiación , Receptores del Ligando Inductor de Apoptosis Relacionado con TNF , Receptores del Factor de Necrosis Tumoral/biosíntesis , Ligando Inductor de Apoptosis Relacionado con TNF , Factor de Transcripción ReIA , Células Tumorales Cultivadas , Factor de Necrosis Tumoral alfa/farmacología , Proteína p53 Supresora de Tumor/genética , Proteína p53 Supresora de Tumor/metabolismo , Proteína bcl-XRESUMEN
Tianeptine is a clinically used antidepressant that has drawn much attention, because this compound challenges traditional monoaminergic hypotheses of depression. It is now acknowledged that the antidepressant actions of tianeptine, together with its remarkable clinical tolerance, can be attributed to its particular neurobiological properties. The involvement of glutamate in the mechanism of action of the antidepressant tianeptine is consistent with a well-developed preclinical literature demonstrating the key function of glutamate in the mechanism of altered neuroplasticity that underlies the symptoms of depression. This article reviews the latest evidence on tianeptine's mechanism of action with a focus on the glutamatergic system, which could provide a key pathway for its antidepressant action. Converging lines of evidences demonstrate actions of tianeptine on the glutamatergic system, and therefore offer new insights into how tianeptine may be useful in the treatment of depressive disorders.
Asunto(s)
Antidepresivos Tricíclicos/farmacología , Monoaminas Biogénicas/metabolismo , Encéfalo/efectos de los fármacos , Ácido Glutámico/metabolismo , Tiazepinas/farmacología , Animales , Ansiolíticos/farmacología , Antidepresivos Tricíclicos/uso terapéutico , Ansiedad/tratamiento farmacológico , Ansiedad/metabolismo , Encéfalo/metabolismo , Trastornos del Conocimiento/tratamiento farmacológico , Depresión/tratamiento farmacológico , Depresión/metabolismo , Modelos Animales de Enfermedad , Humanos , Plasticidad Neuronal/efectos de los fármacos , Estrés Psicológico/metabolismo , Tiazepinas/uso terapéuticoRESUMEN
The induction of tumor cell death by anticancer therapy results from a genetic program of autonomous cell death termed apoptosis. Because the p53 tumor suppressor gene is a critical component for induction of apoptosis in response to DNA damage, its inactivation in cancers may be responsible for their resistance to genotoxic anticancer agents. The cellular response to DNA damage involves a cell-cycle arrest at both the G1/S and G2/M transitions; these checkpoints maintain viability by preventing the replication or segregation of damaged DNA. The arrest at the G1 checkpoint is mediated by p53-dependent induction of p21WAF1/CIP1, whereas the G2 arrest involves inactivation of p34cdc2 kinase. Following DNA damage, p53-deficient cells fail to arrest at G1 and accumulate at the G2/M transition. We demonstrate that abrogation of G2 arrest by caffeine-mediated activation of p34cdc2 kinase results in the selective sensitization of p53-deficient primary and tumor cells to irradiation-induced apoptosis. These data suggest that pharmacologic activation of p34cdc2 kinase may be a useful therapeutic strategy for circumventing the resistance of p53-deficient cancers to genotoxic anticancer agents.
Asunto(s)
Apoptosis/efectos de los fármacos , Médula Ósea/efectos de los fármacos , Linfocitos T CD4-Positivos/efectos de los fármacos , Linfocitos T CD8-positivos/efectos de los fármacos , Proteína Quinasa CDC2/metabolismo , Cafeína/farmacología , Tolerancia a Radiación/efectos de los fármacos , Proteína p53 Supresora de Tumor/deficiencia , Animales , Apoptosis/efectos de la radiación , Médula Ósea/efectos de la radiación , Linfocitos T CD4-Positivos/efectos de la radiación , Linfocitos T CD8-positivos/efectos de la radiación , Daño del ADN , Activación Enzimática/efectos de los fármacos , Femenino , Fase G2/efectos de los fármacos , Genes p53 , Masculino , Ratones , Ratones Noqueados , Proteína p53 Supresora de Tumor/fisiologíaRESUMEN
AIMS: To develop appropriate statistical approaches to plan and evaluate proficiency tests for the enumeration of Escherichia coli, addressing, in particular, a possible but frequently unavoidable lack of test sample homogeneity. METHODS AND RESULTS: Each of 50 laboratories analysed two samples of a stabilized suspension of E. coli in duplicate, using various media, inoculation methods, and incubation times and conditions. In parallel, the E. coli suspension was tested by the organiser for homogeneity and stability. Escherichia coli counts followed a log-normal distribution. After eliminating, by Youden analysis, two data sets that were considered outliers and eight data sets for underperformance of the laboratories (substantial lack of repeatability), the standard deviation of the mean was about 0·06 log(10) units. There was no evidence of bimodality of the data. Lack of homogeneity of distribution of bacteria had a strong effect on measurement uncertainty, in addition to laboratory bias and method repeatability. The homogeneity decreases during storage of the individual test vials; this effect could be modelled by the known kinetics of inactivation of micro-organisms. The results were confirmed by Monte Carlo simulations. CONCLUSIONS: By a tailored analysis of proficiency testing data, it is possible to distinguish the effect of lack of homogeneity, laboratory bias and method repeatability, on the measurement uncertainty. SIGNIFICANCE AND IMPACT OF THE STUDY: A statistic tool is provided to solve problems related to lack of stability of microbiological test material and to separate the effects of sample inhomogeneity from the performance of the individual laboratory.